The/DT
transcriptionally/RB
active/JJ
factors/NNS
mediating/VBG
the/DT
effect/NN
of/IN
the/DT
HTLV-I/NN
Tax/NN
transactivator/NN
on/IN
the/DT
IL-2R/NN
alpha/NN
kappa/NN
B/NN
enhancer/NN
include/VBP
the/DT
product/NN
of/IN
the/DT
c-rel/NN
proto-oncogene/NN
./.

The/DT
transactivator/NN
HTLV-I/NN
Tax/NN
activates/VBZ
the/DT
promoter/NN
of/IN
the/DT
gene/NN
coding/VBG
for/IN
the/DT
interleukin/NN
2/CD
alpha-chain/JJ
receptor/NN
(/(
IL-2R/NN
alpha/NN
)/)
via/IN
a/DT
kappa/NN
B/NN
site/NN
that/WDT
can/MD
bind/VB
several/JJ
protein/NN
species/NNS
of/IN
the/DT
rel/NN
family/NN
./.
=====
Tax1/NN
strongly/RB
activates/VBZ
the/DT
enhancer/NN
activity/NN
of/IN
this/DT
motif/NN
,/,
in/IN
both/CC
epithelial/JJ
HeLa/NN
and/CC
lymphoid/JJ
Jurkat/NN
cells/NNS
./.
=====
This/DT
activation/NN
was/VBD
not/RB
observed/VBN
in/IN
undifferentiated/JJ
embryocarcinoma/NN
F9/NN
cells/NNS
./.
=====
Overexpression/NN
of/IN
the/DT
p50/NN
,/,
p65/NN
and/CC
Rel/NN
proteins/NNS
in/IN
these/DT
cells/NNS
showed/VBD
that/IN
significant/JJ
activation/NN
of/IN
the/DT
IL-2R/NN
alpha/NN
kappa/NN
B/NN
site/NN
was/VBD
observed/VBN
only/RB
with/IN
Rel/NN
and/CC
Rel/NN
plus/CC
p65/NN
./.
=====
Moreover/RB
,/,
whereas/IN
both/CC
Tax/NN
and/CC
phorbol/NN
12-myristate/NN
13-acetate/NN
(/(
PMA/NN
)/)
are/VBP
able/JJ
to/TO
efficiently/RB
induce/VB
the/DT
binding/NN
of/IN
NF-kappa/NN
B/NN
to/TO
the/DT
IL-2R/NN
alpha/NN
kappa/NN
B/NN
site/NN
,/,
PMA/NN
is/VBZ
functionally/RB
inactive/JJ
./.
=====
Using/VBG
the/DT
DNA/NN
affinity/NN
precipitation/NN
assay/NN
,/,
we/PRP
observed/VBD
that/IN
Tax1/NN
is/VBZ
able/JJ
to/TO
efficiently/RB
induce/VB
the/DT
binding/NN
of/IN
Rel/NN
,/,
whereas/IN
PMA/NN
is/VBZ
not/RB
./.
=====
This/DT
established/VBD
a/DT
clear/JJ
difference/NN
between/IN
both/DT
stimuli/NNS
,/,
indicating/VBG
that/IN
Rel/NN
is/VBZ
the/DT
functionally/RB
active/JJ
factor/NN
./.
=====
We/PRP
conclude/VBP
from/IN
these/DT
results/NNS
that/IN
the/DT
functional/JJ
activity/NN
of/IN
members/NNS
of/IN
the/DT
rel/NN
family/NN
is/VBZ
regulated/VBN
by/IN
their/PRP$
interaction/NN
with/IN
DNA/NN
and/CC
that/IN
Rel/NN
can/MD
be/VB
a/DT
potent/JJ
transcriptional/JJ
activator/NN
on/IN
specific/JJ
kappa/NN
B/NN
sites/NNS
./.